Insurance Product Filing Requirements Japan (PDF Checklist & JFSA Routes)

Every new retail insurance product sold in Japan must pass through the Financial Services Agency (JFSA) before it reaches a single policyholder, and understanding the insurance product filing requirements Japan PDF documentation expects is the difference between a smooth 90-day approval and months of costly back-and-forth. This guide distils the key provisions of the Insurance Business Act, the FSA’s Comprehensive Guidelines for Supervision of Insurance Companies, and current 2026 supervisory priorities into a single, practitioner-focused resource. It is designed for in-house counsel, compliance officers, actuarial teams and product managers at domestic insurers and foreign branches preparing a JFSA filing.

Below you will find the exact approval routes, a milestone-by-milestone timeline, a full required-documents checklist and pre-consultation best practice, everything your team needs compiled into one actionable filings pack.

What you need now:

• Choose the right route. Standard prior approval, standardised-product pathway, notification-only or branch filing, each carries different documentary burdens.
• Plan for 90 days. The JFSA’s standard processing period is up to 90 days from administrative acceptance; internal preparation should begin well before submission.
• Assemble the filings pack. Policy wording, premium rate tables, actuarial memorandum, statement of business procedures and product-governance evidence are all required, see the full document checklist below.

Legal and Regulatory Framework for Insurance Product Filing Requirements Japan

Insurance Business Act, Key Articles Including Article 186

The statutory foundation for every product filing is the Act on Insurance Business (保険業法, Hoken-gyō Hō). Enacted in 1995 and amended multiple times since, this Act establishes the licensing, conduct-of-business and product-approval regime administered by the JFSA. Under the official English translation published by the Ministry of Justice, several articles are critical for filing teams:

• Article 4 (Licence application). Sets out the documents an insurer must submit when applying for or varying its licence, including articles of incorporation, a business plan and a statement of business procedures (jigyō hōhōsho).
• Article 123 (Statement of business procedures). Requires every licensed insurer to maintain and file a statement of business procedures covering policy terms, premium calculation methods, liability reserves and policyholder-dividend policy.
• Article 186 (Prior approval of premium rates and policy conditions for certain lines). This provision mandates that changes to premium rates or policy conditions for designated insurance lines receive JFSA approval before the product is marketed. Article 186 effectively enshrines the “prior review” doctrine: no new retail product may be offered to the public until the agency has confirmed that its terms protect policyholders, its pricing is actuarially sound and its disclosures are adequate.

Beyond individual articles, the Act empowers the JFSA to issue subordinate regulations, ordinances and supervisory guidelines that flesh out the filing process in practice.

FSA Comprehensive Guidelines, Scope and 2026 Updates

The Comprehensive Guidelines for Supervision of Insurance Companies, published and periodically updated by the FSA, translate statutory requirements into operational expectations. These guidelines specify the precise information the regulator reviews when assessing a product filing, including pricing adequacy, policyholder protection, suitability controls and distribution-channel oversight. The 2026 edition places heightened emphasis on product governance, requiring insurers to demonstrate that boards have formally approved the target market, distribution strategy and remuneration arrangements for every new product before filing. Industry observers expect this supervisory focus to tighten further as Japan aligns with international best practices promoted by the IAIS.

JFSA Approval Routes, Which Route for Which Product

Not every insurance product filing follows the same path. The route your organisation must take depends on the product line, the policyholder segment and the filing entity’s legal status. This section maps the four principal routes for JFSA approval Japan teams should evaluate before assembling their documentation.

Standard Prior Approval

The default route for any new retail life, non-life or third-sector (medical/accident) product sold to individual consumers. Under this route, the insurer submits a full filings pack, including policy wording, premium rate schedules, actuarial memorandum and governance evidence, and the JFSA conducts a substantive review within the standard 90-day processing period. This route applies whenever the product introduces new terms, new coverage features or materially revised pricing.

Standardised Products, What Qualifies

Certain product amendments that fall within parameters already approved by the JFSA, or that replicate structures the regulator has pre-cleared as “standardised”, may qualify for a simplified filing. Examples include minor rate adjustments within pre-approved bands, riders that mirror existing approved riders, or renewal filings where terms remain substantially unchanged. The documentary burden is lighter, often limited to a variation notice, an updated rate table and a brief actuarial note, and processing times can be shorter than the full 90-day window.

Notification vs. Approval

For specific product categories, principally large-corporate and reinsurance contracts, the Insurance Business Act permits a notification-only procedure rather than full prior approval. The insurer files a notice with the JFSA and may proceed after a prescribed waiting period unless the regulator raises objections. This route is unavailable for individual retail products and is rarely appropriate for health insurance product filing requirements Japan teams handle.

Branch and Foreign Insurer Route

Foreign insurers operating through a Japan branch must follow the same prior-approval requirements as domestic companies for retail products. However, branches often face additional documentation requests, certified translations of the parent company’s articles of incorporation, audited group financial statements and evidence that the product has received any required home-country approval. Pre-consultation with the JFSA is strongly recommended for complex foreign-origin products.

90-Day Timeline, Practical Calendar and Milestones

The JFSA’s standard processing period for a standard prior-approval filing is up to 90 days from administrative acceptance. In practice, the clock begins only once the regulator confirms that the submission is formally complete. Teams that treat the 90-day window as a single block often underestimate the internal preparation required. The milestone breakdown below reflects the typical sequence.

Day 0: Pre-Check and Submission

Before formal submission, the applicant’s compliance team should conduct a final completeness review against the JFSA’s published document requirements. Submissions are made to the Insurance Business Division of the Supervisory Bureau. The “Day 0” date is the date of administrative acceptance, not the postal or electronic dispatch date.

Days 1–14: Completeness Check

During this phase the JFSA confirms that all required documents are present, correctly formatted and, where applicable, translated into Japanese. If the submission is incomplete, the regulator issues a deficiency notice and the 90-day clock pauses until the gaps are remedied. Early indications suggest that incomplete filings are the single most common cause of delay.

Days 15–60: Substantive Review

The JFSA’s product review team evaluates the filing against the criteria in the Comprehensive Guidelines: actuarial soundness of premium rates, adequacy of policyholder disclosures, fairness of policy conditions, suitability of the target market and appropriateness of the distribution channel. Written queries (shitsumon-sho) may be issued to the applicant during this phase; prompt, well-documented responses help keep the timeline on track.

Days 61–90: Queries and Finalisation

Outstanding queries are resolved, any requested amendments to policy wording or disclosure materials are confirmed, and the JFSA issues its decision. Approval takes the form of a written notification. If the regulator is not satisfied, it may request further revisions (which reset the relevant portion of the review) or, in rare cases, refuse approval with reasons.

Required Documents, Master Insurance Product Filing Requirements Japan PDF Checklist

The document checklist below represents the core filings pack for a standard prior-approval submission. It consolidates the requirements set out in the Insurance Business Act and the FSA’s Comprehensive Guidelines into a single reference table. Product teams should adapt the list for their specific product line, health insurance product filing requirements Japan regulators expect, for example, include additional clinical-exclusion schedules and benefit-design summaries.

Basic Documents

These items are required for every filing regardless of product type:

Product-Specific Documents (Wordings, Premiums, Rates)

Governance and Compliance Evidence

• Product governance framework summary. Document describing the insurer’s internal product approval process, target-market assessment methodology and ongoing monitoring plan.
• Suitability policy. Confirms the standards agents and brokers must meet when recommending the product.
• Remuneration and incentive structure. Disclosure of commission rates, bonuses and any non-monetary incentives tied to product distribution.
• Complaints-handling procedure. Outlines how policyholder complaints related to the new product will be managed.

Distribution and Marketing Materials

• Draft sales brochures and advertising materials. Must comply with the FSA’s fair-disclosure requirements; include risk warnings and cooling-off disclosures.
• Agent/broker training materials. Evidence that distributors will be trained on the product’s features, exclusions and target market.
• Digital-channel disclosures. If the product will be sold online, include screenshots or wireframes of the customer journey showing disclosure points.

All core documents must be submitted in Japanese. Foreign-branch applicants may submit parent-company materials in English with certified Japanese translations. There is no apostille requirement for documents originating in Japan; foreign documents may require consular authentication depending on the source jurisdiction.

Pre-Consultation with the JFSA, What to Prepare

When to Pre-Consult

Pre-consultation is not mandatory under the Insurance Business Act. However, it is strongly encouraged by the FSA for novel products, products with complex risk-sharing features, foreign-origin products being adapted for the Japanese market, and any filing where the applicant is uncertain whether standard or notification-only procedures apply. Industry observers note that a well-conducted pre-consult can reduce the risk of substantive queries during the formal 90-day review and shorten the overall approval timeline.

How to Structure the Meeting

Pre-consultation meetings are typically requested by letter or email to the relevant JFSA division. A practical agenda should cover:

• Product overview, one-page summary of coverage, target market and pricing rationale.
• Regulatory-route confirmation, the applicant’s proposed filing route and the basis for that choice.
• Key questions, specific areas of uncertainty (e.g., whether a rider requires separate approval, whether a particular exclusion is permissible).
• Supporting evidence, market-comparison data, consumer-testing results or home-country approval documentation.

Post-Consult Steps

After the meeting, the applicant should prepare a written record of the discussion points and any guidance received, circulate it internally to legal, actuarial and compliance teams, and incorporate the regulator’s feedback into the filings pack before formal submission. While JFSA pre-consultation guidance is not legally binding, departing from it without explanation is likely to trigger queries during the formal review.

Product Governance and 2026 Supervisory Focus

Governance Evidence Required

The JFSA’s 2026 supervisory priorities place product governance at the centre of the filing process. Insurers must now demonstrate, at the point of filing, that the product has been through a formal internal approval process. The likely practical effect is that the regulator will scrutinise board minutes, product-committee records and sign-off chains more closely than in previous years. Key evidence includes:

• Product approval minutes. Board or product-committee minutes recording the decision to develop and file the product, including a documented target-market assessment.
• Consumer-testing documentation. Evidence that the product’s terms, disclosures and pricing have been tested with representative consumers or consumer-advocacy groups.
• Ongoing monitoring plan. A description of how the insurer will track post-launch performance, complaints and suitability outcomes.

Distribution Oversight

Insurers must show that distribution channels are appropriate for the product’s target market. This includes confirming that agents and brokers have received product-specific training, that remuneration structures do not incentivise mis-selling, and that digital-distribution platforms include adequate disclosure checkpoints. The Comprehensive Guidelines for Supervision of Insurance Companies now explicitly require insurers to document their distribution-oversight arrangements in the filings pack.

Consumer-Testing Documentation

While not a statutory requirement, the FSA’s 2026 guidance strongly recommends that insurers conduct and document consumer testing before filing. Testing may take the form of focus groups, online surveys, or reviews by independent consumer panels. Results should be summarised in a short report appended to the governance-evidence section of the filings pack.

Post-Approval Obligations and IFRS 17 Japan Considerations

Reporting and Disclosure

Approval is not the end of the compliance journey. Once a product is on-market, the insurer must file periodic reports with the JFSA covering sales volumes, claims experience, complaint data and any material deviations from the business-plan projections submitted at filing. Material changes to premium rates or policy conditions after approval require a fresh filing, either a full prior-approval submission or, for minor adjustments, a standardised-product variation notice.

IFRS 17, What to Include in Filings

Japan has been progressively aligning its insurance accounting standards with IFRS 17 through guidance issued by the Accounting Standards Board of Japan (ASBJ). While Japanese domestic accounting standards remain the primary reporting framework for most insurers, large internationally active groups are increasingly required to prepare IFRS 17-compliant disclosures. For product filings, the practical implication is that actuarial memoranda and reserve calculations should reference both Japanese GAAP and, where applicable, IFRS 17 measurement models, particularly the Building Blocks Approach (BBA) or the Premium Allocation Approach (PAA). Industry observers expect JFSA examiners to pay closer attention to IFRS 17-aligned disclosures as international convergence continues.

Filing Obligations by Entity Type, Comparison Table

Conclusion

Filing an insurance product in Japan demands precision, the right approval route, a complete documentary submission and clear evidence of product governance. As the JFSA’s 2026 supervisory focus on consumer protection and distribution oversight intensifies, compliance teams that invest in thorough preparation will navigate the 90-day approval window far more efficiently. Use the insurance product filing requirements Japan PDF checklist in this guide as your starting framework, adapt it to your product line and consult a specialist before submission. For access to qualified insurance and reinsurance practitioners in Japan, visit the Global Law Experts lawyer directory.

Sources

1. Financial Services Agency (FSA), Comprehensive Guidelines for Supervision of Insurance Companies
2. Insurance Business Act, Japanese Law Translation (Ministry of Justice)
3. Ministry of Health, Labour and Welfare (MHLW)
4. IFRS Foundation, IFRS 17 Insurance Contracts
5. Accounting Standards Board of Japan (ASBJ)
6. International Association of Insurance Supervisors (IAIS)
7. e-Gov, Government of Japan Official Publications